Advanced Biomed Inc. (ADVB): Net Income

Annual figures by period end, from SEC filings.

$6.68M

Year ended 2026-06-30

2024-06-30 Net Income (USD) 2026-06-30

Period ended	Net Income	Change YoY	Source filing
2026-06-30	$6.68M	n/m	2026-10-13, From 2025-07-01
2025-06-30	-$3.26M	n/m	2026-10-13, From 2024-07-01
2024-06-30	-$2.78M	n/a	2025-10-08, From 2023-07-01

Net Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Net Income	Change YoY
Advanced Biomed Inc. (ADVB)	2026-06-30	$6.68M	n/m
YD Bio Ltd (YDES)	2025-12-31	-$8.31M	n/m
Aclarion, Inc. (ACON)	2025-12-31	-$7.23M	n/m
BioNexus Gene Lab Corp (BGLC)	2025-12-31	-$2.98M	n/m
CapForce Inc. (CFOR)	2025-12-31	$23.62M	+97.0%
First Choice Healthcare Solutions, Inc. (FCHS)	2025-12-31	-$6.96M	n/m
American Shared Hospital Services (AMS)	2025-12-31	-$1.55M	n/m
Exagen Inc. (XGN)	2025-12-31	-$19.95M	n/m
Biodesix Inc (BDSX)	2025-12-31	-$35.27M	n/m

Compare ADVB, YDES, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗